Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Language
Publication year range
1.
J Neuroimmunol ; 362: 577764, 2022 01 15.
Article in English | MEDLINE | ID: mdl-34823118

ABSTRACT

Muscarinic-acetylcholine-receptors (mAChRs) modulate intestinal homeostasis, but their role in inflammation is unclear; thus, this issue was the focus of this study. BALB/c mice were treated for 7 days with muscarine (mAChR/agonist), atropine (mAChR/antagonist) or saline. Small-intestine samples were collected for histology and cytofluorometric assays in Peyer's patches (PP) and lamina propria (LP) cell-suspensions. In LP, goblet-cells/leukocytes/neutrophils/MPO+ cells and MPO/activity were increased in the muscarine group. In PP, IFN-γ+/CD4+ T or IL-6+/CD4+ T cell numbers were higher in the muscarine or atropine groups, respectively. In LP, TNF-α+/CD4+ T cell number was higher in the muscarine group and lower in the atropine.


Subject(s)
Inflammation/immunology , Intestinal Mucosa/immunology , Receptors, Muscarinic/immunology , Animals , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Intestine, Small/immunology , Mice , Mice, Inbred BALB C , Muscarinic Agonists/pharmacology , Peyer's Patches/drug effects , Peyer's Patches/immunology
2.
Nutrients ; 13(8)2021 Aug 19.
Article in English | MEDLINE | ID: mdl-34445013

ABSTRACT

Bovine lactoferrin (bLf), a component of milk and a dietary supplement, modulates intestinal immunity at effector and inductor sites. Considering the regional difference in intestinal compartments and the dynamics of local cytokine-producing cells in the gut across time, the aim of this work was to characterize the effects of bLf on the proximal small intestine in a BALB/c murine model of oral administration. Male BALB/c mice were treated with oral bLf vs. saline control as mock by buccal deposition for 28 days. Intestinal secretions were obtained at different time points and cells were isolated from Peyer's patches (PP) and lamina propria (LP) of the proximal small intestine as representative inductor and effector sites, respectively. Total and specific anti-bLF IgA and IgM were determined by enzyme-immuno assay; the percentages of IgA+ and IgM+ plasma cells (PC) and cytokine-producing CD4+ T cells of PP and LP were analyzed by flow cytometry. We found that total and bLf-specific IgA and IgM levels were increased in the intestinal secretions of the bLf group in comparison to mock group and day 0. LP IgA+ PC and IgM+ PC presented an initial elevation on day 7 and day 21, respectively, followed by a decrease on day 28 in comparison to mock. Higher percentages of CD4+ T cells in LP were found in the bLf group. Cytokines-producing CD4+ T cells populations presented a pattern of increases and decreases in the bLf group in both LP and PP. Transforming growth factor beta (TGF-ß)+ CD4+ T cells showed higher percentages after bLf administration with a marked peak at day 21 in both LP and PP in comparison to mock-treated mice. Oral bLf exhibits complex immune properties in the proximal small intestine, where temporal monitoring of the inductor and effector compartments reveals patterns of rises and falls of different cell populations. Exceptionally, TGF-ß+ CD4+ T cells show consistent higher numbers after bLf intervention across time. Our work suggests that isolated measurements do not show the complete picture of the modulatory effects of oral bLf in immunological sites as dynamic as the proximal small intestine.


Subject(s)
Immunity, Mucosal/drug effects , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Lactoferrin/administration & dosage , Peyer's Patches/drug effects , T-Lymphocytes, Helper-Inducer/drug effects , Administration, Oral , Animals , Cytokines/metabolism , Immunoglobulin A/metabolism , Immunoglobulin M/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestine, Small/immunology , Intestine, Small/metabolism , Male , Mice, Inbred BALB C , Peyer's Patches/immunology , Peyer's Patches/metabolism , Phenotype , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism , Time Factors , Transforming Growth Factor beta/metabolism
3.
Acta Cir Bras ; 30(9): 624-31, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26465107

ABSTRACT

PURPOSE: To assess whether deoxycholic acid (DOC) and lithocholic acid (LCA) administered in a period of six months in a concentration of 0.25% may have a carcinogenic role in mice colon. METHODS: The study used C57BL6 female mice divided into four groups. The control group received a balanced diet and the others received diets supplemented with 0.25% DOC, 0.25% LCA and 0.125% DOC+0.125% LCA, respectively. After euthanasia, the lesions found in the resected gastrointestinal tracts were stained with hematoxylin-eosin and examined microscopically. RESULTS: No gastrointestinal tract changes were observed in the control group, while hyperplastic Peyer's patches in the small intestine, flat adenomas with mild dysplasia and chronic colitis at the level of the colon were found in all three test groups. The colonic lesions prevailed in the proximal colon. The highest number of flat adenoma lesions (8), hyperplasia of Peyer's patches (25) and chronic colitis (2) were found in mice fed with diet and LCA. CONCLUSION: Precancerous or cancerous pathological lesions could not be identified. Instead, adenomatous colonic injuries occurred in a shorter period of time (six months), compared to the reported data.


Subject(s)
Bile Acids and Salts/toxicity , Carcinogens/toxicity , Cholagogues and Choleretics/toxicity , Colon/drug effects , Deoxycholic Acid/toxicity , Lithocholic Acid/toxicity , Adenoma/chemically induced , Animals , Carcinogenicity Tests , Colitis/chemically induced , Colon/pathology , Colonic Neoplasms/chemically induced , Disease Models, Animal , Feces/chemistry , Female , Mice, Inbred C57BL , Peyer's Patches/drug effects , Time Factors
4.
Acta cir. bras ; Acta cir. bras;30(9): 624-631, Sep. 2015. tab, ilus
Article in English | LILACS | ID: lil-761497

ABSTRACT

ABSTRACTPURPOSE:To assess whether deoxycholic acid (DOC) and lithocholic acid (LCA) administered in a period of six months in a concentration of 0.25% may have a carcinogenic role in mice colon.METHODS:The study used C57BL6 female mice divided into four groups. The control group received a balanced diet and the others received diets supplemented with 0.25% DOC, 0.25% LCA and 0.125% DOC+0.125% LCA, respectively. After euthanasia, the lesions found in the resected gastrointestinal tracts were stained with hematoxylin-eosin and examined microscopically.RESULTS:No gastrointestinal tract changes were observed in the control group, while hyperplastic Peyer's patches in the small intestine, flat adenomas with mild dysplasia and chronic colitis at the level of the colon were found in all three test groups. The colonic lesions prevailed in the proximal colon. The highest number of flat adenoma lesions (8), hyperplasia of Peyer's patches (25) and chronic colitis (2) were found in mice fed with diet and LCA.CONCLUSION: Precancerous or cancerous pathological lesions could not be identified. Instead, adenomatous colonic injuries occurred in a shorter period of time (six months), compared to the reported data.


Subject(s)
Animals , Female , Bile Acids and Salts/toxicity , Carcinogens/toxicity , Cholagogues and Choleretics/toxicity , Colon/drug effects , Deoxycholic Acid/toxicity , Lithocholic Acid/toxicity , Adenoma/chemically induced , Carcinogenicity Tests , Colitis/chemically induced , Colon/pathology , Colonic Neoplasms/chemically induced , Disease Models, Animal , Feces/chemistry , Peyer's Patches/drug effects , Time Factors
5.
J Agric Food Chem ; 59(10): 5299-304, 2011 May 25.
Article in English | MEDLINE | ID: mdl-21504180

ABSTRACT

The aim of the present study was to evaluate the effect of the oral administration of kefiran on the balance of immune cells in a murine model. Six week old BALB/c mice were treated with kefiran (300 mg/L) for 0, 2 and 7 days. Kefiran treatment increased the number of IgA+ cells in lamina propria after 2 and 7 days. Percentage of B220+/MHCII(high) cells in mesenteric lymph nodes (2 days) and Peyer's patches (7 days) was higher compared to untreated control mice. An increase of macrophages (F4/80+ cells) was observed in lamina propria and peritoneal cavity (2 and 7 days). In contrast, at day 7, macrophage population decreased in Peyer's patches. These results show the ability of kefiran to modify the balance of immune cells in intestinal mucosa. This property could be highly relevant for the comprehension of the probiotic effect attributed to kefir.


Subject(s)
Immune System/cytology , Immune System/drug effects , Polysaccharides/administration & dosage , Animals , Cell Count , Immunoglobulin A/analysis , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Lymph Nodes/cytology , Lymph Nodes/drug effects , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Models, Animal , Peyer's Patches/cytology , Peyer's Patches/drug effects
6.
J Leukoc Biol ; 78(1): 62-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15809287

ABSTRACT

Chitosan is a cationic polysaccharide derived from the partial deacetylation of chitin, which exhibits particular properties: interacts with negatively charged sites on the cell surface; changes the permeability of intestinal epithelium, enhancing the uptake of peptides and proteins; and activates leukocytes. Antigens coadministered or encapsulated with the polysaccharide show improved mucosal and systemic humoral immune responses, although the mechanism is poorly understood. Herein, we characterized in Peyer's patches mesenteric lymph nodes and spleen molecular events triggered after oral administration of chitosan in the absence of protein antigen. Sixteen hours after feeding, we studied the uptake and distribution of the polysaccharide, the phenotype of recruited antigen-presenting cells (APC), the induction of cytokines such as tumor necrosis factor alpha, interleukin (IL)-12, IL-4, IL-10, and transforming growth factor-beta (TGF-beta), and the activation of T lymphocytes. We show here that the uptake of chitosan at inductive mucosal sites involves CD11b/c+ APC and that chitosan feeding increases the percentage of OX62+ dendritic cells, which up-regulate the major histocompatibility complex class II antigens without changing the expression of costimulatory CD80 or CD86 molecules. The polysaccharide elicits the release of IL-10 as well as the expression of IL-4 and TGF-beta in mucosa, and in spleen, the activation of CD3+ T cells occurs. Our results demonstrate that chitosan acts by enhancing the T helper cell type 2 (Th2)/Th3 microenvironment in the mucosa. A single dose of this polysaccharide exhibits local and systemic effects, and its activity could be relevant in the maintenance of the intestinal homeostasis.


Subject(s)
Antigen-Presenting Cells/drug effects , Chemotaxis, Leukocyte/drug effects , Chitosan/metabolism , Chitosan/pharmacology , Lymphoid Tissue/drug effects , Lymphoid Tissue/immunology , Administration, Oral , Animals , Antigen-Presenting Cells/immunology , Antigens, Surface/immunology , Chemotaxis, Leukocyte/immunology , Chitosan/immunology , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/drug effects , Dendritic Cells/immunology , Female , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Mucous Membrane/drug effects , Mucous Membrane/immunology , Peyer's Patches/drug effects , Peyer's Patches/immunology , Phenotype , Rats , Rats, Wistar , Spleen/drug effects , Spleen/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Th2 Cells/drug effects , Th2 Cells/immunology , Up-Regulation/drug effects , Up-Regulation/immunology
8.
Clin Immunol Immunopathol ; 80(2): 147-54, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8764559

ABSTRACT

To define the alterations provoked by malnutrition during suckling (20 pups/dam) in the gut-associated lymphoid tissues of rats, Peyer patch (PP) and mesenteric lymph node (MLN) cells were studied by flow cytometry. After weaning (21 days of age), rats malnourished during suckling (MNR) showed an increase in the CD4+ CD45RC+ subset together with a decrease in the CD4+ CD45RC- subset (P < 0.01). These alterations remained even after 3 weeks of refeeding with stock diet. The CD4+CD8+ subset was not increased in the MNR, indicating that a release of cortical thymocytes did not occur. At weaning the percentage of CD4+Thy1+ cells was decreased in the MNR, indicating a low number of cells released from the thymus. When the B cell lineage was studied, we found a decreased percentage of precursors in the bone marrow and a decreased percentage of mature B cells in the periphery. When the MNR were immunized intra-PP with cholera toxin (CT) after 1 week of refeeding, the specific IgG and IgA and IgM antibody-forming cells (measured by ELISPOT) were diminished in the PP, MLN, and spleen when compared to the age-matched controls (P < 0.001). These results were coincident with the ELISA titers obtained in the sera and in the intestinal fluids. When CT was administered after 2 weeks of refeeding, the number of IgM anti-toxin AFC approached control values, but the number of IgA and IgG AFC continued to be low. When 3 weeks of refeeding was allowed before the CT delivery, the immune response in the MNR approached control values. These results indicate that malnutrition during suckling provokes alterations in B and T lymphocytes and produces a lack in the induction of the primary and secondary immune responses in the GALT which reversed after 3 weeks of refeeding.


Subject(s)
Animals, Suckling/immunology , B-Lymphocytes/immunology , Cholera Toxin/immunology , Intestinal Mucosa/immunology , Nutrition Disorders/immunology , Peyer's Patches/immunology , T-Lymphocytes/immunology , Animals , Antitoxins/biosynthesis , Antitoxins/blood , Antitoxins/chemistry , B-Lymphocytes/metabolism , Body Weight/immunology , Immunization , Intestinal Secretions/immunology , Lymph Nodes/cytology , Mesentery , Peyer's Patches/drug effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL